CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-22 | LEVIN JEREMY M CEO | Purchase | +75,000 | $2.00 | $150K | 4,676,529 |
| 2018-08-27 | Ward Ana SVP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +11,250 | 11,250 | ||
| 2018-08-27 | Daly Timothy SVP,Finance & Corp. Controller | Grant or award · Employee Stock Option (right to buy) | +11,250 | 11,250 | ||
| 2018-08-27 | Rakhit Amit CMO and PMO | Grant or award · Employee Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2018-08-27 | Haasner Dirk SVP, Global Regulatory Affairs | Grant or award · Employee Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2018-08-14 | Bernstein Karen Director | Purchase | +10,000 | $6.23 | $62K | 10,000 |
| 2018-08-14 | WILLIAMS DOUGLAS E Director | Purchase | +5,000 | $6.49 | $32K | 5,000 |
| 2018-06-07 | WILLIAMS DOUGLAS E Director | Grant or award · Stock Option (Right to Buy) | +5,813 | 5,813 | ||
| 2018-06-07 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +5,813 | 5,813 | ||
| 2018-06-07 | Duncan Barbara Gayle Director | Grant or award · Stock Option (Right to Buy) | +5,813 | 5,813 | ||
| 2018-06-07 | Bernstein Karen Director | Grant or award · Stock Option (Right to Buy) | +5,813 | 5,813 | ||
| 2018-01-19 | Werber Yaron CBO, CFO, Sec. and Treas. | Grant or award · Employee Stock Option (Right to Buy) | +131,000 | 131,000 | ||
| 2018-01-19 | Ward Ana SVP and General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-01-19 | Rakhit Amit CMO and PMO | Grant or award · Employee Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2018-01-19 | LEVIN JEREMY M CEO | Grant or award · Employee Stock Option (Right to Buy) | +290,000 | 290,000 | ||
| 2018-01-19 | Haasner Dirk SVP, Global Regulatory Affairs | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-01-19 | During Matthew President and CSO | Grant or award · Employee Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2018-01-19 | Daly Timothy SVP,Finance & Corp. Controller | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2017-09-05 | Ward Ana SVP and General Counsel | Grant or award · Stock Option Grant (Right to Buy) | +95,000 | 95,000 | ||
| 2017-08-25 | LEVIN JEREMY M CEO | Purchase | +15,334 | $7.15 | $110K | 4,601,529 |
Page 9 of 10 · 189 trades